News

Avidity Biosciences (RNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...
As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...
Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor Plus as ...
RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...
Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...
Tantalizing clues in 4-billion-year-old asteroid Bennu samples could reveal particular molecular formations that some ...